Cargando…
219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106936/ http://dx.doi.org/10.1016/j.jid.2023.03.222 |
| _version_ | 1785026510833319936 |
|---|---|
| author | Fernández, A. Mesas Solimani, F. Bodner, E. Carevic-Neri, M. Jakovljevicova, T. Philipp, A. Nast, A. Worm, M. Hilke, F. Meier, K. Ghoreschi, K. |
| author_facet | Fernández, A. Mesas Solimani, F. Bodner, E. Carevic-Neri, M. Jakovljevicova, T. Philipp, A. Nast, A. Worm, M. Hilke, F. Meier, K. Ghoreschi, K. |
| author_sort | Fernández, A. Mesas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106936 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101069362023-04-17 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid Fernández, A. Mesas Solimani, F. Bodner, E. Carevic-Neri, M. Jakovljevicova, T. Philipp, A. Nast, A. Worm, M. Hilke, F. Meier, K. Ghoreschi, K. J Invest Dermatol Article Published by Elsevier Inc. 2023-05 2023-04-17 /pmc/articles/PMC10106936/ http://dx.doi.org/10.1016/j.jid.2023.03.222 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Fernández, A. Mesas Solimani, F. Bodner, E. Carevic-Neri, M. Jakovljevicova, T. Philipp, A. Nast, A. Worm, M. Hilke, F. Meier, K. Ghoreschi, K. 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title | 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title_full | 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title_fullStr | 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title_full_unstemmed | 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title_short | 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid |
| title_sort | 219 clinical and immunological impact of booster immunization with recombinant mrna vaccines for sars-cov-2 in patients with pemphigus and bullous pemphigoid |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106936/ http://dx.doi.org/10.1016/j.jid.2023.03.222 |
| work_keys_str_mv | AT fernandezamesas 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT solimanif 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT bodnere 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT carevicnerim 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT jakovljevicovat 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT philippa 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT nasta 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT wormm 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT hilkef 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT meierk 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid AT ghoreschik 219clinicalandimmunologicalimpactofboosterimmunizationwithrecombinantmrnavaccinesforsarscov2inpatientswithpemphigusandbullouspemphigoid |